Disc Medicine, Inc. (IRON) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Disc Medicine reported revenue of $0. Net income was -$212.2M, or -$6.01 per diluted share. Operating activities generated -$180.4M of cash, leaving -$181.3M of free cash flow. At fiscal year end, Disc Medicine held $806.9M in total assets against $67.1M in total liabilities, including $91.1M of cash and equivalents.
Open the full interactive Disc Medicine financials → Quarterly statements, key ratios, valuation history and price charts.
Disc Medicine Key Stats
| Share Price | $56.60 |
|---|---|
| Market Cap | $2.19B |
| 52-Week Range | $55.95 – $94.11 |
| Shares Outstanding | 38.7 million (basic, 2026 Q2) |
Disc Medicine Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$69.0M | -$47.5M | -$91.1M | -$129.7M | -$236.0M |
| Pre-Tax Income | -$71.9M | -$46.8M | -$76.3M | -$109.0M | -$211.8M |
| Income Tax | — | — | $99,000 | $355,000 | $361,000 |
| Net Income | -$71.9M | -$46.8M | -$76.4M | -$109.4M | -$212.2M |
| Diluted EPS | -$53.40 | -$45.05 | -$3.42 | -$3.96 | -$6.01 |
Disc Medicine Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$62.3M | -$60.5M | -$63.5M | -$59.5M |
| Diluted EPS | -$1.77 | -$1.71 | -$1.65 | -$1.54 |
Disc Medicine Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $136.6M | $194.6M | $360.4M | $192.4M | $91.1M |
| Current Assets | $140.1M | $198.5M | $365.7M | $493.6M | $803.9M |
| Total Assets | $140.4M | $200.2M | $368.0M | $496.8M | $806.9M |
| Current Liabilities | $14.8M | $22.6M | $21.4M | $23.3M | $36.6M |
| Total Long-Term Debt | $5.4M | — | — | $28.3M | $29.2M |
| Total Liabilities | $15.6M | $23.6M | $22.9M | $53.2M | $67.1M |
| Shareholders' Equity | $124.8M | $176.6M | $345.1M | $443.6M | $739.8M |
Disc Medicine Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$59.7M | -$42.3M | -$73.5M | -$93.9M | -$180.4M |
| Cash From Investing | $344,000 | -$151,000 | -$89,000 | -$292.3M | -$394.3M |
| Cash From Financing | $191.5M | $149.0M | $239.4M | $218.3M | $473.4M |
| Free Cash Flow | -$59.8M | -$42.4M | -$73.6M | -$94.4M | -$181.3M |
Figures from Disc Medicine's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Disc Medicine financials page for every line item.
Disc Medicine Company Profile
| Ticker | IRON |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Watertown, Massachusetts |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001816736 |
Frequently Asked Questions
What was Disc Medicine's revenue in fiscal 2025?
Disc Medicine (IRON) reported revenue of $0 for fiscal 2025.
What is Disc Medicine's annual revenue history?
Disc Medicine's annual revenue by fiscal year: 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was Disc Medicine's net income in fiscal 2025?
Disc Medicine reported net income of -$212.2M for fiscal 2025.
What was Disc Medicine's earnings per share (EPS) in fiscal 2025?
Disc Medicine's diluted EPS was -$6.01 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Disc Medicine generate in fiscal 2025?
Disc Medicine generated -$181.3M of free cash flow in fiscal 2025.
What was Disc Medicine's revenue last quarter?
In its most recent reported quarter (2026 Q2), Disc Medicine reported revenue of $0.
How much debt does Disc Medicine have?
Disc Medicine reported $29.2M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Disc Medicine are outstanding?
Disc Medicine reported a weighted average of 38.7 million basic shares outstanding in 2026 Q2.
What is Disc Medicine's market cap?
Based on its latest closing price, Disc Medicine (IRON) has a market capitalization of about $2.19B.
When does Disc Medicine's fiscal year end?
Disc Medicine's fiscal year end, as registered with the SEC, is December 31.
Where is Disc Medicine headquartered?
Disc Medicine lists its business address in Watertown, Massachusetts in its SEC filings.